Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Szydlo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Experimental Hematology|October 12, 1999
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now standF Dazzi, R M Szydlo, J M Goldman
British Journal of Haematology|January 1, 1997
Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year periodD G Savage, R M Szydlo, J M Goldman
Transplantation Proceedings|October 26, 2010
Sign of the Zodiac as a predictor of survival for recipients of an allogeneic stem cell transplant for chronic myeloid leukaemia (CML): an artificial associationR M Szydlo, I Gabriel, E Olavarria, et al.
Bone Marrow Transplantation|February 16, 2000
Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemiaP Konstantinidou, R M Szydlo, A Chase, et al.
Statistics in Medicine|October 24, 2000
Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate modelJ P Klein, R M Szydlo, C Craddock, et al.
Clinical Radiology|July 16, 1999
CT and MRI manifestations of central nervous system infection following allogeneic bone marrow transplantationS C Coley, H R Jäger, R M Szydlo, et al.
British Journal of Haematology|June 10, 2000
Summary curves for patients transplanted for chronic myeloid leukaemia salvaged by a donor lymphocyte infusion: the current leukaemia-free survival curveJ P Klein, N Keiding, Y Shu, et al.
British Journal of Haematology|November 14, 1997
Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapseD G Savage, R M Szydlo, A Chase, et al.
Transplantation|October 15, 1995
In vitro cytokine profiles and their relevance to rejection following renal transplantationE R Kaminski, A Kaminski, M R Bending, et al.
British Journal of Haematology|March 8, 2007
Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell doseC Fozza, R M Szydlo, M M Abdel-Rehim, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Experimental Hematology|October 12, 1999
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now standF Dazzi, R M Szydlo, J M Goldman
British Journal of Haematology|January 1, 1997
Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year periodD G Savage, R M Szydlo, J M Goldman
Transplantation Proceedings|October 26, 2010
Sign of the Zodiac as a predictor of survival for recipients of an allogeneic stem cell transplant for chronic myeloid leukaemia (CML): an artificial associationR M Szydlo, I Gabriel, E Olavarria, et al.
Bone Marrow Transplantation|February 16, 2000
Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemiaP Konstantinidou, R M Szydlo, A Chase, et al.
Statistics in Medicine|October 24, 2000
Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate modelJ P Klein, R M Szydlo, C Craddock, et al.
Clinical Radiology|July 16, 1999
CT and MRI manifestations of central nervous system infection following allogeneic bone marrow transplantationS C Coley, H R Jäger, R M Szydlo, et al.
British Journal of Haematology|June 10, 2000
Summary curves for patients transplanted for chronic myeloid leukaemia salvaged by a donor lymphocyte infusion: the current leukaemia-free survival curveJ P Klein, N Keiding, Y Shu, et al.
British Journal of Haematology|November 14, 1997
Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapseD G Savage, R M Szydlo, A Chase, et al.
Transplantation|October 15, 1995
In vitro cytokine profiles and their relevance to rejection following renal transplantationE R Kaminski, A Kaminski, M R Bending, et al.
British Journal of Haematology|March 8, 2007
Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell doseC Fozza, R M Szydlo, M M Abdel-Rehim, et al.
Pageof 4